What's breaking now, across thousands of outlets.
Researchers from the University of Liverpool and the University of Zurich have identified a potential safety consideration involving levetiracetam, one of the world's most commonly prescribed antiseizure medications.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
BioNTech delivered a compelling piece of evidence Monday supporting the development of its CTLA-4 antibody gotistobart in lung cancer.
Researchers at Fox Chase Cancer Center have identified a promising approach to rebuilding tissue after skin cancer surgery that could help some patients avoid more extensive reconstructive procedures.
A new study has revealed why some people with Huntington's disease develop symptoms 10–12 years earlier and experience a more aggressive form of the disease.
A Johns Hopkins Medicine study reports evidence that time-restricted eating (TRE)—a form of intermittent fasting that involves eating only during a consistent daily 8–10-hour window—can cause modest…
Stakeholders across the Ahafo Region including traditional authorities, religious leaders, political office holders, media practitioners, policymakers, and healthcare providers have joined hands to…
The test involves using a dedicated chip and fluorescence analysis, in which fragments of cell-free DNA in the blood are examined for distinct methylation patterns.
